THRL — Target Healthcare Reit Income Statement
0.000.00%
Last trade - 00:00
- £492.47m
- £724.70m
- £67.75m
- 58
- 72
- 50
- 65
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 34.3 | 44.3 | 50 | 63.9 | 67.7 |
Cost of Revenue | |||||
Gross Profit | 34.2 | 44.2 | 49.9 | 63.7 | 67.6 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.29 | 8.37 | 1.29 | 8.16 | 64.2 |
Operating Profit | 33 | 35.9 | 48.7 | 55.7 | 3.56 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 29.9 | 31.6 | 43.9 | 49.1 | -6.57 |
Provision for Income Taxes | |||||
Net Income After Taxes | 29.9 | 31.6 | 43.9 | 49.1 | -6.57 |
Net Income Before Extraordinary Items | |||||
Net Income | 29.9 | 31.6 | 43.9 | 49.1 | -6.57 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 29.9 | 31.6 | 43.9 | 49.1 | -6.57 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.081 | 0.074 | 0.094 | 0.082 | -0.01 |
Dividends per Share |